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ABSTRACT  
Stability of Donepezil Hydrochloride(DONE) was investigated using stability indicating Reverse phase high performance liquid chromatography 
(RP-HPLC) utilizing C-18 column and mobile phase containing Acetonitrile:Water (pH 3.5)  in ratio of 40:60 at flow rate of 1 ml min-1. Peaks of 
donepezil and degradation products were well resolved at retention times < 7 min. Stability was performed in 0.1N hydrochloric acid, 0.1N 
sodium hydroxide, 3 % hydrogen peroxide, neutral, photolytic and dry heat conditions. Fast hydrolysis was seen in alkaline condition as 
compared to oxidative and neutral conditions. Methods was validated with respect to linearity, precision, accuracy, specificity and robustness 
LOQ and LOD. It was also found to be stability indicating, and therefore suitable for the routine analysis of Donepezil hydrochloride in the 
pharmaceutical formulation. 
 





Donepezil is a reversible inhibitor of the enzyme acetylcholinesterase 
(AchE) approved for use in Alzheimer’s disease.[1] The pathogenesis of 
Alzheimer’s disease attributed some of them to a deficiency of 
cholinergic neurotransmission. Therefore, AChE inhibitors, which 
prevent the hydrolysis of acetylcholine, may exert their therapeutic 
effect by enhancing cholinergic function. The first AChE inhibitor 
(tacrine) has been used, however, associated with a high incidence of 
gastrointestinal (GI) side effects and hepatotoxicity.[2] Donepezil is a 
potent and more selective AChE inhibitor in the central nervous 
system with little effect on peripheral tissue, therefore, has a lower 
incidence of GI and cardiovascular adverse effects. The drug produces 
modest improvements in cognitive scores and has a long half-life 
allowing once daily dosing. Donepezil is slowly absorbed from the GI 
tract.[3] The present work describes the utility of RP- HPLC in forced 
degradation-stability study under different chemical conditions. 
EXPERIMENTAL 
Chemical 
Donepezil HCl was gifted by  Sun Pharmaceutical Pvt. Ltd. Broda, 
Gujarat 
Methanol HPLC Grade(FINAR) 
HPLC Water 
HCl  AR Grade (MERCK) 
NaOH AR Grade (MERCK) 
H2O2 AR Grade (RANKEM) 





Acetonitrile HPLC Grade(FINAR) 
Instrumentation 
Company : Shimadzu 
Model No : SPD 10 A-LC 
Softwer : WINCHROME SOFTWER 
Operation : Semi Automatic 
Semi micro analytical balance (Sartorius CD2250, Germany) was used 
for weighing purpose.  
HPLC water was obtained using Arium®611VF(Sartorius). 
Magnetic stirrer (1 MLH, Remi) was used for mixing purpose. 
pH tutor (313927, Eutech Instruments) was used for pH 
measurement. 
Sonication of solutions were done using Ultrasonic cleaner (D 
120/1H, Trans-O-Sonic). 
Nylon membrane filters (0.22 µm, 47 mm D) 
All volumetric glasswares used were calibrated.  
DEGRADATION STUDIES 
All degradation studies were done at a drug concentration of 50µg 
ml-1. For acid decomposition studies, drug was dissolved in 0.1N HCl 
and solution was boiled under reflux for 1 hr. The studies in alkaline 
conditions were done in 0.1N NaOH boiling under reflux for 1 hr. For 
study in neutral conditions, drug in water was boiled under reflux for 
1 hr. For oxidative conditions, initial studies were done in 3% H2O2  
YESHA K PATEL1*, M N NOOLVI1, HASUMATI RAJ1, MEGHNA P PATEL1 
                                                                                                                              Patel al. 
   Innovare Journal of medical science Vol 4, Issue 1, 2016,1-6  
solution. The solution was kept at room temperature for 1 hr. 
Photolytic studies were done by exposing solid drug directly to uv 
light for 2 hr. Thermal decomposition studies were performed by 





Standard and sample solutions were injected in column. The 
chromatogram was run for appropriate time duration with degassed 
mobile phase, mixture of Acetonitrile:Water pH 3.5 (40:60 v/v), using  
UV detector (SPD-20AV) at wavelength 230 nm. The chromatogram 
was stopped after separation was achieved completely. Data related 
to peak like area, height, retention time, resolution etc was recorded 
using CLASS-VP software (version 2.31). 
 
Table1:Chromatographic conditions of developed method 
 
Sr no HPLC Conditions Results 
1 Elution Isocratic 
2 Mobile Phase Acetonitrile:Water pH 3.5 (40:60 v/v) 
3 Diluent Acetonitrile 
4 Flow Rate 1 ml/min 
5 Detector   UV Visible 
6 Injection volume 20 µL 
7 Wavelength 230 nm 
8 Column Temperature Room temperature 
9 Run time 10 min 
10 Column InertSustainSwiftTM C18  (250mm×4.6mm i.d.) 5μm 
 
STANDARD CHROMATOGRAM 
                 Blank 
 
 






Table 2:Mobile Phase: Acetonitrile:Water pH 3.5(40:60 v/v) 
Name  Retention time(min) Theoretical Plates Tailing Factor 
Donepezil HCl 5.08 8528.92 0.51 
Table 3:Observed value for system suitability test 
Sr No System SuitabilityParameter Donepezil HCl IP’2007 specification 
1. Number of Theoretical Plates (N) 8528.92 >2000 
2. Resolution - >2 
3. Tailing Factor(Tf) 0.51 <2 
 




Specificity was measured by injecting a blank solution and another 
blank solution which was previously spiked with common excipients. 
No any interference by excipients was observed. The entire base line 
was found stable. 
Linearity Range 
The linearity range for Donepezil HCl was found to be 10-100 μg/ml. 
Correlation co-efficient for calibration curve of Donepezil HCl(DONE) 
was found to be 0.998. 
The regression line equation for Donepezil HCl is as follows: 
y = 25514x + 41169 
Where, y= corresponding peak area from CLASS 
VP software(v2.31) 




      Fig 1:Chromatogram of standard Donepezil HCl 
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Table 4:calibration data and calibration curve
Sr No. Donepezil  HCl  
          (μg/ml) 
Mean Area ±SD (n=6) 
1. 10 317958 ±620 
2. 20 533316 ±3349 
3. 30 787252 ±3677 
4. 40 1068169 ±4172 
5. 50 1326223 ±2028 
   
PRECISION 
Intraday Precision 
Table 5:The results for intraday precision for donepezil hcl are presented in table. 
Conc.  
(µg/ml)  
Peak Area ± SD (n=3)  %RSD  Mean % RSD  
10 318860 ± 992 0.31  
0.21 30 787616 ± 405 0.05 
50 1329368 ± 3805 0.28 




Peak Area ± SD (n=3)  %RSD  Mean % RSD  
10 326043 ± 1340  0.41   
0.50  30 801079 ± 3947  0.19  
50 1414963 ± 13058  0.92  
ACCURACY 
Table 7:The data for accuracy study for donepezil hcl are presented in table. % recovery for donepezil hcl was found to be in 
range of 99.0-100.53%. 
Conc 
μg/ml 
%Spiking Total Conc 
μg/ml 
Peak Area Recovered Amt. 
μg/ml 
%Recovery Mean % Recovery 




10 80%(8) 18 462472 18.12 100.70 
10 100%(10) 20 517568 20.28 101.42 
10 120%(12) 22 560704 21.97 99.89 
LOD AND LOQ 
 
Table 8:The data for lod and loq for donepezil hcl are presented in table. lod for donepezil hcl was 1.3527μg/ml and loq was 
4.0993μg/ml. 
Sr No. Parameter Donepezil HCl 
1. S.D of the Y-intercepts of 6 calibration curve 41169 
2. Mean slope of the 6 calibration curves. 25514 
3. LOD = 3.3 × (SD/Slope) (μg/ml) 0.85 μg/ml  









Twenty ‘AERICEP’ Tablets (containing 10 mg of Donepezil  HCl) 
were accurately weighed and ground to fine powder.  
An accurately weighed quantity equivalent to 100 mg of 
Donepezil HCl (DONE) from the formulation fine powder was 
transferred to 100 mL volumetric flask and 40-50 ml 
Acetonitrile  is added to dissolve the drug, Sonicate for 15 
mins.Volume is made up to the mark with the Acetonitrile.  
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Table 10: Robustness 
Sr No. Factor Conc Level Mean(n=3) ±SD %RSD 
1 Change in flow rate 50µg/ml  0.8 
 
              1532054 ± 6104 0.39 
1.2 1332303 ±7842 0.53 
2 Change in  
wavelength 
50µg/ml 232 1485170±4023 0.27 
228 1337647±8685 0.64 
Table 11:Summary of validation parameters: 
Sr No. Parameters Result 
1. Wavelength (nm) 230 nm 
2. Linearity range (μg/ml)  10-50 µg/ml  
3. Standard Regression equation  Y=25514x + 41169 
4. Correlation coefficient (R2)  0.998 






6. % Recovery (Accuracy, n = 3)  100.29% 
7. LOD (μg/ml)  0.85 
8. LOQ (μg/ml)  2.59 
9. Robustness 





10. Assay (% Label claim)  103.46% 
 
FORCE DEGRADATION STUDIES  
Acid degradation 
100 mg drug dissolve in 1 ml Acetonitrile and dilute up 100 ml of 
0.1N HCl. Pipette out 0.5 ml and solution neutralize with equivalent 
amount of 0.1 N NaOH and dilute with acetonitrile up to 10 ml .Then 
this solution is kept for 1 hour at , 70˚C and peak is recorded . Sample 
withdrawal  at 0 min, after 10 min, 30 min, 1hr at 70˚C. 
Alkali degradation 
100 mg drug dissolve in 1 ml Acetonitrile and dilute up 100 ml of 
0.1N NaOH. Pipette out 0.5 ml and solution neutralize with equivalent 
amount of 0.1 N HCl and dilute with acetonitrile up to 10 ml .Then 
this solution is kept for 1 hour at 70˚C and peak is recorded. Sample 
withdrawal at 0 min, after 10 min, 30 min, 1hr at 70˚C. 
Oxidation 
3% H2O2  was taken in a 100ml volumetric flask then accurately 
weighed 100mg bulk drug was dissolved in it and  then volume is  
 
made by 3 % H2O2.Then this solution is kept for 1 hr and peak is 
recorded .Sample withdrawal at 0 min, after 10 min, 30 min, 1hr . 
Neutral Condition 
First Distilled water was taken in a 100 ml volumetric flask then 
accurately weighed 100 mg bulk drug was dissolved in it., volume is 
made by Water(1000 ppm). Then this solution is kept for 1 hour at 
70˚C and peak is recorded .Sample withdrawal at 0 min, after 10 min, 
30 min, 1hr at 70˚C. 
Photolytic Condition 
100mg of bulk drug was put  into the petridish  and placed under 
direct  UV Light for 1 hr.10mg is weighed and make upto 10 ml, using 
diluent Acetonitrile and chromatogram was recorded. Similar 
Procedure is followed for 2 hr. 
 Thermal Condition 
100 mg of bulk drug was taken in a cleaned Petridish and  was put it 











Donepezil HCl 10 mg 30 31.92 103.40% 
STANDARD TEST 
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was weighed and   dissolved in 10 ml of diluent Acetonitrile and chtomatogram was recorded.  Similar Procedure is followed for 2hr. 
 
ACID DEGRADATION 







PHOTOLYTIC DEGRADATION                                                                   
 
THERMAL DEGRADATION
Table 12: Summary of overall degradation study 
CONDITION  % DEGRADATION  
 AFTER 1 HR  AFTER 2 HR  
ACIDIC  60.05% - 
BASIC  92.31% - 
NEUTRAL  13.58% - 
OXIDATION  78.05% - 
PHOTOLYTIC  1.62% 3.23% 
THERMAL  10.76% 12.48% 
 
DISCUSSIONS 
The stability of the new donepezil hydrochloride is investigated using 
stability indicating RP-HPLC procedure. The method permits 
detection and quantitation of donepezilhydrochloride in the presence 
of its degradation products. It was subjected to stress conditions as 
per ICH guidelines. The drug was found to degrade in alkaline, 
oxidative and neutral conditions while it was found to be stable under 
photolytic and dry heat conditions. The drug can be analyzed 
specifically in the presence of different chromophoric degradation 
products by using isocratic conditions and mobile phase containing 
Acetonitrile :Water (pH 3.5)in the ratio of 40 :60. The method was 
validated for parameters like linearity, precision, accuracy, specificity 
and robustness.  
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